Personalized care may hold the key as survival in advanced endometrial cancer remains poor regardless of surgery type or ...

Another study by Venkat et al. emphasized the differences in costs, charges and actual reimbursements between laparoscopic and robotic surgery for endometrial cancer. [] Various economic aspects ...

Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...

The cancer often silent in its early stages, is now increasingly affecting women under 50, including those in their early 30s ...

The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 ...

Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.

In TP53 wild-type advanced or recurrent endometrial cancer, selinexor improved multiple time-to-event outcomes vs placebo.

Uterine cancer is the most common gynecologic cancer in the U.S. In 2024, there were almost 70,000 cases, ... Elkin pointed to decreases in hysterectomies -- surgery to remove the uterus ...